Manufacturers Life Insurance Company, The Alnylam Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 191,382 shares of ALNY stock, worth $49.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
191,382
Previous 329,037 41.84%
Holding current value
$49.4 Million
Previous $80 Million 34.16%
% of portfolio
0.05%
Previous 0.08%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$233.81 - $287.01 $32.2 Million - $39.5 Million
-137,655 Reduced 41.84%
191,382 $52.6 Million
Q2 2024

Aug 14, 2024
SELL
$143.31 - $247.0 $1.14 Million - $1.97 Million
-7,988 Reduced 2.37%
329,037 $80 Million
Q1 2024

May 14, 2024
SELL
$146.51 - $198.2 $556,005 - $752,169
-3,795 Reduced 1.11%
337,025 $50.4 Million
Q4 2023

Feb 13, 2024
SELL
$151.41 - $196.57 $2.28 Million - $2.96 Million
-15,043 Reduced 4.23%
340,820 $65.2 Million
Q3 2023

Nov 15, 2023
BUY
$170.77 - $211.65 $4.99 Million - $6.18 Million
29,209 Added 8.94%
355,863 $63 Million
Q2 2023

Aug 11, 2023
SELL
$185.01 - $212.05 $3.06 Million - $3.51 Million
-16,566 Reduced 4.83%
326,654 $62 Million
Q1 2023

May 15, 2023
SELL
$182.66 - $235.53 $1.04 Million - $1.34 Million
-5,692 Reduced 1.66%
337,528 $67.6 Million
Q4 2022

Aug 11, 2023
SELL
$185.53 - $241.31 $105 Million - $137 Million
-567,340 Reduced 62.31%
343,220 $81.6 Million
Q4 2022

Feb 13, 2023
SELL
$185.53 - $241.31 $92 Million - $120 Million
-495,795 Reduced 59.09%
343,220 $81.6 Million
Q3 2022

Aug 11, 2023
SELL
$138.54 - $232.0 $103 Million - $173 Million
-745,275 Reduced 45.01%
910,560 $182 Million
Q3 2022

Nov 03, 2022
SELL
$138.54 - $232.0 $113 Million - $190 Million
-816,820 Reduced 49.33%
839,015 $169 Million
Q2 2022

Aug 11, 2023
SELL
$120.42 - $169.29 $11.5 Million - $16.1 Million
-95,228 Reduced 5.44%
1,655,835 $242 Million
Q2 2022

Aug 15, 2022
SELL
$120.42 - $169.29 $41.2 Million - $57.9 Million
-341,927 Reduced 17.12%
1,655,835 $241 Million
Q1 2022

Aug 11, 2023
BUY
$127.18 - $173.91 $180 Million - $246 Million
1,413,535 Added 418.79%
1,751,063 $286 Million
Q1 2022

May 20, 2022
BUY
$127.18 - $173.91 $37.5 Million - $51.3 Million
295,092 Added 17.33%
1,997,762 $327 Million
Q4 2021

Feb 16, 2022
SELL
$159.56 - $209.29 $4.59 Million - $6.02 Million
-28,763 Reduced 1.66%
1,702,670 $289 Million
Q3 2021

Nov 12, 2021
SELL
$169.75 - $207.73 $4.14 Million - $5.06 Million
-24,375 Reduced 1.39%
1,731,433 $327 Million
Q2 2021

Aug 12, 2021
BUY
$128.63 - $176.89 $19.4 Million - $26.7 Million
150,950 Added 9.41%
1,755,808 $298 Million
Q1 2021

May 03, 2021
BUY
$126.83 - $175.69 $17.9 Million - $24.7 Million
140,769 Added 9.61%
1,604,858 $227 Million
Q4 2020

Feb 12, 2021
BUY
$122.97 - $147.0 $37.1 Million - $44.3 Million
301,315 Added 25.91%
1,464,089 $190 Million
Q3 2020

Nov 09, 2020
SELL
$121.19 - $165.49 $7.23 Million - $9.87 Million
-59,658 Reduced 4.88%
1,162,774 $169 Million
Q2 2020

Aug 10, 2020
SELL
$104.21 - $156.44 $5.96 Million - $8.95 Million
-57,222 Reduced 4.47%
1,222,432 $181 Million
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $98 Million - $141 Million
1,052,417 Added 463.14%
1,279,654 $139 Million
Q4 2019

Feb 14, 2020
SELL
$74.51 - $124.23 $567,170 - $945,638
-7,612 Reduced 3.24%
227,237 $26.2 Million
Q3 2019

Nov 12, 2019
SELL
$70.9 - $87.82 $341,525 - $423,028
-4,817 Reduced 2.01%
234,849 $19 Million
Q2 2019

Aug 14, 2019
BUY
$65.86 - $92.79 $2.07 Million - $2.92 Million
31,429 Added 15.09%
239,666 $17.4 Million
Q1 2019

May 13, 2019
SELL
$72.76 - $93.45 $455,041 - $584,436
-6,254 Reduced 2.92%
208,237 $19.5 Million
Q4 2018

Feb 14, 2019
BUY
$62.67 - $88.33 $89,367 - $125,958
1,426 Added 0.67%
214,491 $15.6 Million
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $18.4 Million - $25.7 Million
209,846 Added 6518.98%
213,065 $18.6 Million
Q2 2018

Aug 14, 2018
SELL
$88.31 - $107.8 $1,854 - $2,263
-21 Reduced 0.65%
3,219 $317,000
Q1 2018

May 15, 2018
BUY
$115.92 - $148.54 $8,694 - $11,140
75 Added 2.37%
3,240 $386,000
Q4 2017

Feb 08, 2018
BUY
$114.49 - $139.98 $38,926 - $47,593
340 Added 12.04%
3,165 $402,000
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $204,897 - $334,112
2,825
2,825 $332,000

Others Institutions Holding ALNY

# of Institutions
639
Shares Held
108M
Call Options Held
1.15M
Put Options Held
1.07M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email